What is Lightspeed Microscopy?
Lightspeed Microscopy Inc. is at the forefront of revolutionizing pathology with a comprehensive, full-stack solution designed for non-destructive, high-resolution 3D imaging of large tissue samples. Established in 2018 and based in Seattle, WA, the company leverages novel chemistry, a patented high-throughput light-sheet microscope, and cloud-based AI software to provide unprecedented depth and detail in pathological analysis. This technology offers a new dimension to understanding disease at a sub-cellular level.
How much funding has Lightspeed Microscopy raised?
Lightspeed Microscopy has raised a total of $4M across 1 funding round:
Series A
$4M
Series A (2021): $4M with participation from Dynamk Capital
Key Investors in Lightspeed Microscopy
Dynamk Capital
Dynamk Capital is a New York-based venture capital firm that specializes in investing in life science industrials, focusing on tools, technologies, and services essential for the discovery, development, and production of life-saving therapies. The firm aims to support innovative companies that are advancing the field of life sciences.
What's next for Lightspeed Microscopy?
With this substantial enterprise-level backing, Lightspeed Microscopy is poised for accelerated growth and market expansion. The strategic investment will likely fuel further research and development, enhance its AI capabilities, and scale its commercial operations. The company's trajectory suggests a strong focus on solidifying its position as a leader in digital pathology, enabling more precise diagnostics and potentially impacting therapeutic development pathways.
See full Lightspeed Microscopy company page
